PE-backed SightMT acquires Hatsis Laser Vision

SightMD, a portfolio company of Chicago Pacific Founders, has acquired Hatsis Laser Vision, a provider of ophthalmic care in Long Island and the greater New York City area. No financial terms were disclosed.


SightMD (or the “Company”), a leading multi-specialty ophthalmology platform and a portfolio company of Chicago Pacific Founders, today announced a strategic partnership with Alexander P. Hatsis, Physician, P.C. d/b/a Hatsis Laser Vision (“Hatsis Laser Vision”). The partnership expands SightMD’s presence on Long Island, adding an additional Nassau County location and three providers to SightMD’s current footprint of 32 locations and 70+ providers across Long Island and the Greater New York City area.

Hatsis Laser Vision is one of the region’s pre-eminent providers of comprehensive ophthalmic care, including laser cataract surgery, LASIK laser vision correction, and retinal services. Hatsis Laser Vision is led by its founder, Alexander Hatsis, M.D., F.A.C.S., with support from fellowship-trained retinal specialist, Philip Bonanno, M.D. and optometrist, Dr. Leah Shanfeld. The acquisition builds upon SightMD’s leading position in New York and adds the Company’s first LASIK suite in Nassau County.

“Hatsis Laser Vision and its providers are a perfect addition to our growing team of clinically-excellent, patient-focused providers,” said Dr. Jeffrey Martin, a Co-Founder and President SightMD. “I have known and admired Dr. Hatsis for many years, and, today, feel privileged to have the opportunity to call him my partner.”

Dr. Hatsis remarked, “The more we learned about the genesis of SightMD and its mission, the more certain we were in our desire to work together in our pursuit of next-generation, personalized ophthalmic patient care. My partners and I are very enthusiastic to partner with a physician-led organization whose values are so closely aligned with ours. The entire transaction process with SightMD was one of partnership and collaboration, and we are couldn’t be more excited to join the Company.”

Dr. Hatsis was one of the expert U.S. surgeons to help gain FDA approval for laser vision correction, and the first surgeon to perform LASIK on Long Island in 1995. He also participated in FDA approval of Phakic Implant Lenses and was the first surgeon on Long Island to treat keratoconus with collagen cross linking in 2007. In addition to research, patient care and teaching responsibilities, Dr. Hatsis is passionate about service work, where he frequently participates in global medical missions to underserved areas. He has been voted a Castle Connelly “Top Doctor” for six consecutive years, a Newsday “Top Doctor” for five consecutive years, and a Humanitarian of the Year by the Salvation Army.
Schedules and hours for Drs. Hatsis, Bonanno and Shanfeld will remain unchanged pursuant to the partnership. Hatsis Laser Vision represents the seventh practice to join SightMD since the Company partnered with Chicago Pacific Founders.

About SightMD
SightMD is a rapidly-growing integrated ophthalmic provider group, offering patients access to over 50 ophthalmic surgeons and specialists through the convenience of 32 locations spanning the east end of Long Island, Westchester County and Manhattan. SightMD’s track record of providing clinically-excellent care spans over 50 years, and its services include laser cataract surgery and lens implantation, glaucoma management, retinal disorder treatment, corneal services, neuro-ophthalmology, LASIK laser vision correction, oculoplastic surgery, pediatric ophthalmology, and audiology. SightMD provides its physicians with world-class management services, including a 24/7 call center, billing, credentialing, human resources and other services, enabling them to continue delivering best-in-class care to patients in SightMD’s community. SightMD is backed by Chicago Pacific Founders, a leading middle market private equity firm which focuses exclusively on partnerships with growth-oriented companies in the healthcare services sector. For more information about SightMD, please visit